Natalicchio MI

No ORCID on file · 2 papers in corpus
2022
Acta bio-medica : Atenei Parmensis ·doi:10.23750/abm.v93i4.11695

Background and aim of the workBRCA1/2 are tumour-suppressor genes involved in DNA homologous recombination and ovarian cancer development.  The study evaluated the risk of tumor cancer in women presenting the BRCA mutations.MethodsRisk-redu…

2018
Oncotarget ·doi:10.18632/oncotarget.24959

IntroductionAbout 25% of ovarian cancers can be classified as hereditary. Of these, 80-90% are correleted with the Hereditary Breast-Ovarian Cancer Syndrome (HBOC), which is linked to BRCA 1/2 genes mutations. Our study was set up to study …